Arkadios Wealth Advisors’s Biogen BIIB Stock Holding History

Arkadios Wealth Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.04M	Buy	4,806 +25	+0.5%	+$4.78K	0.02%	790
2026 Q1	$877K	Buy	4,781 +206	+5%	+$38K	0.01%	849
2025 Q4	$805K	Buy	4,575 +1,679	+58%	+$274K	0.02%	797
2025 Q3	$406K	Sell	2,896 -107	-4%	-$14.5K	0.01%	1034
2025 Q2	$377K	Sell	3,003 -351	-10%	-$43.7K	0.01%	964
2025 Q1	$459K	Buy	+3,354	New	+$479K	0.02%	737
2022 Q1	–	Sell	-897	Closed	-$215K	–	561
2021 Q4	$215K	Sell	897 -494	-36%	-$127K	0.03%	533
2021 Q3	$393K	Sell	1,391 -152	-10%	-$49.8K	0.06%	344
2021 Q2	$534K	Buy	1,543 +334	+28%	+$101K	0.07%	314
2021 Q1	$338K	Buy	1,209 +98	+9%	+$26.4K	0.06%	326
2020 Q4	$272K	Buy	1,111 +995	+858%	+$257K	0.06%	274
2020 Q3	$32.5K	Sell	116 -2	-2%	-$558	0.02%	494
2020 Q2	$33.2K	Buy	118 +24	+26%	+$7.21K	0.02%	440
2020 Q1	$29.7K	Sell	94 -29	-24%	-$8.8K	0.02%	420
2019 Q4	$41.1K	Buy	+123	New	+$34.1K	0.02%	340

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Arkadios Wealth Advisors's BIIB Position: Q2 2026 in Review

Arkadios Wealth Advisors increased its Biogen (BIIB) stake by 0.52% in Q2 2026, buying an estimated $4.78K and bringing the position to 4,806 shares worth $1.04M. The position accounts for 0.02% of the portfolio, ranked #790.

Arkadios Wealth Advisors first reported a position in BIIB in Q4 2019 and has held it in 15 quarters since. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Arkadios Wealth Advisors held 4,806 shares of Biogen worth $1.04M as of Q2 2026.
Arkadios Wealth Advisors bought 25 Biogen shares in Q2 2026, an estimated $4.78K.
Biogen made up 0.02% of Arkadios Wealth Advisors's portfolio in Q2 2026, its #790 holding.
Arkadios Wealth Advisors first reported a position in Biogen in Q4 2019 and has held it in 15 quarters since.
1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Arkadios Wealth Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.